Zusammenfassung
54 Patienten mit akuter und chronischer Myokarditis wurden auf Antikörper und Seruminhibitionsfaktoren untersucht. Bei 11 Patienten konnte eine Virusätiologie gesichert werden, bei 17 Patienten bestand der Verdacht auf eine „chronische“ Myokarditis. Aus dem Vergleich der Antikörpermuster zwischen Patienten mit bekannter Virusätiologie und ätiologisch nicht definierter Myokarditis konnte gefolgert werden, daß vor allem Antikörper gegen Sarkolemm und Gefäßendothel Marker eines virusinduzierten Prozesses am Myokard sind. 10 der 11 Patienten mit Influenza, Coxsackie B3-und Coxsackie B4-Myokarditis hatten diese Konstellation. 15 der 26 Patienten mit ätiologisch unklarer Myokarditis wiesen dasselbe Antikörpermuster auf, während bei 17 Patienten mit Verdacht auf chronische Myokarditis antiendotheliale Antikörper und antisarkolemmale Antikörper seltener nachweisbar waren. 65% der Patienten mit „chronischer“ Myokarditis wiesen Antikörper gegen Kerne mit einem Titer bis zu 1:40 auf.
Während Seruminhibitionsfaktoren (SIF) bei allen Patienten mit akuter Virusmyokarditis und bei 11 von 26 Patienten mit akuter, ätiologisch nicht definierter Myokarditis nachweisbar waren, persistierten sie nur bei 3 Patienten mit chronischer Myokarditis, bei denen aufgrund des Auftretens von antinukleären Faktoren und der fehlenden antiendothelialen und antisarkolemmalen Antikörper ein autoimmuner Prozeß angenommen werden könnte.
Die Untersuchungen zeigen, daß eine ätiologische Klassifizierung unklarer Myokarditiden mit serologischen Markern möglich ist und daß Seruminhibitionsfaktoren bei akuten Myokarditiden passager und bei autoimmunen Myokarditiden persistierend vorkommen können.
Summary
54 patients with acute and “chronic” myocarditis were tested for autoantibodies and serum inhibition factors. 11 patients had a viral myocarditis, 17 a “chronic” myocarditis. By comparing the antibody pattern of sera of patients with defined viral myocarditis with those of patients with myocarditis of unknown etiology we could demonstrate that antisarcolemmal (ASA) and antiendothelial antibodies (AEA) are markers of a viral involvement in heart disease. 10 of the 11 patients with Coxsackie B and Influenza virus myocarditis demonstrated this pattern.
15 out of 26 patients with undefined myocarditis showed the same antibody pattern, in sera of 17 patients with features suggestive of “chronic” myocarditis antiendothelial and antisarcolemmal antibodies occurred less frequently. The latter patients showed antinuclear antibodies in 65% with titres up to 1:40.
Whereas SIF could be demonstrated in all patients with acute viral myocarditis, and in 11 out of 26 patients with acute undefined myocarditis in the early period and only in 3 patients with “chronic” myocarditis, SIF persisted in these 3 patients with chronic myocarditis in whom we suspected an autoimmune process.
Our investigation demonstrates that an etiological classification of undefined myocarditis can be obtained by serological markers and that serum inhibition factors occur transiently in acute and continuously in autoimmune myocarditis.
Abbreviations
- AEA:
-
antiendothelial antibodies
- AFA:
-
antifibrillary antibodies
- AHA:
-
antiheart antibodies
- AMA:
-
antimitochondrial antibodies
- ANA:
-
antinuclear antibodies
- ASA:
-
antisarcolemmal antibodies
- CFT:
-
complement fixation test
- DNA:
-
des-oxy-ribonucleic acid
- ECG:
-
electrocardiogram
- IFA:
-
antiinterfibrillary antibodies
- IRA:
-
immune regulatory alpha-globulin
- PHA:
-
phytohaemagglutinin
- SIF:
-
serum inhibition factors
- SMA:
-
smooth muscle antibodies
References
Berg, P.A., Brandt, H., Märker, A.: Nachweis und Bedeutung von Antikörpern gegen homologes Gefäßendothel bei Leberund anderen Krankheiten. Verh. Dtsch. Ges. Inn. Med.79, 649–650 (1973)
Berg, P.A., Binder, T., Lindner, H., Bannaski, H., Mass, D., Henning, H., Brügel, H.: Heterogenität mitochondrialer Autoantikörper. Dtsch. Med. Wochenschr.100, 1123–1127 (1975)
Bertrams, J., Kuwert, E., Selmair, H., Reis, H.E., Wiese, W.: Autoantikörper gegen Lymphozyten (CoCoCy) bei Patienten mit verschiedenen Formen der Hepatitis und Cirrhose. Klin. Wochenschr.54, 227–233 (1976)
Bolte, H.D.: Diagnostische Wertigkeit des indirekten Immunfluoreszenztestes zum Nachweis humoraler Antikörper gegen Myokard. Internist16, 180–184 (1975)
Brattig, N., Berg, P.A.: Serum inhibitory factors (SIF) in patients with acute and chronic hepatitis and their clinical significance. Clin. Exp. Immunol.25, 40–49 (1976)
Burch, G.E., De Pasquale, N.P.: Cardiomyopathies. Viral myocarditis. pp. 376–405. London: J. & A. Churchill Ltd. 1964
Burch, G.E., Giles, T.D.: The role of viruses in the production of heart disease. Am. J. Cardiol.29, 231–240 (1972)
Burch, G.E., Giles, T.D.: Viral cardiomyopathy, in: Recent advances in studies on cardiac structure and metabolism. Vol. 2 Cardiomyopathies. Bajusz, E., Rona, G. (eds.). pp. 121–139. München: Urban & Schwarzenberg 1976
Chisari, F.V., Edgington, T.S.: Lymphocyte E rosette inhibitory factor: A regulatory serum lipoprotein. J. Exp. Med.142, 1092–1107 (1975)
Chiu, K.M., Mortensen, R.F., Osmand, A.P., Gewurz, H.: Interactions of alpha-acid glycoprotein with the immune system. I. Purification and effects upon lymphocyte responsiveness. Immunology32, 997–1005 (1977)
Coons, A.H., Kaplan, M.M.: Localization of antigens in tissue cells. I. Improvements in a method for the detection of antigen by means of fluorescent antibody. J. Exp. Med.91, 1–13 (1950)
Cooperband, S.R., Badger, A.M., Mannick, J.A.: Non-hormonal serum suppressive factors. In: Mitogens in Immunobiology. Oppenheim, J.J., Rosenstreich, D.L. (eds.), pp. 555–572. New York, London: Academic Press 1976
Cooperband, S.R., Niberg, R., Schmid, K. et al.: Humoral immunosuppressive factors. Transplant. Proc.8, 225–242 (1976)
De Horatius, R.J., Henderson, C., Strickland, R.G.: Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes. Clin. Exp. Immunol.26, 21–27 (1976)
Fitzgerald, M.G., Hosking, C.S.: Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections. Immunol.30, 33–42 (1976)
Gluckman, J.C., Bonfils, H., Sanchez, F.: Inhibition of complement-dependant rosette information by sera of patients with chronic glomerulonephritis. Clin. Exp. Immunol.26, 247–252 (1976)
Goldstein, I.J., So, L.L., Yand, Y., Callies, Q.C.: Proteincarbohydrate interaction. XIX. The interaction of concanavalin A with IgM and the glycoprotein phytohaemagglutinins of waxbean and the soybean. J. Immunol.103, 695–698 (1969)
Gorcezynski, R., Kontiainen, S., Mitchison, N.A., Tigelaar, R.E.: Antigen-antibody complexes as blocking factors on the T lymphocyte surface. In: Cellular selection and regulation in the immune response. Edelman, G.M. (ed.), pp. 143–154. New York: Raven Press 1974
Havemann, K., Bürger, S., Dosch, H.M.: Phytohämagglutinin (PHA) und Serumproteine in der Lymphozytenkultur. II. Die Präzipitation von Serumproteinen durch PHA. Z. Ges. Exp. Med.153, 308–323 (1970)
Hawkins, B.R., McDonald, M., Dawkins, R.C.: Characterization of immunofluorescent heterophil antibodies which may be confused with autoantibodies. J. Clin. Pathol.30, 299–307 (1977)
Kaplan, M.H., Meyeserian, M.: An immunological reaction between group A streptococcal cells and human heart tissue. Lancet1962 I, 706–710
Kaplan, M.H., Frengley, J.D.: Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, post-cardiotomy and post-infarction syndromes and cardiomyopathies. Am. J. Cardiol.24, 459–473 (1969)
Keller, R.H., Tomasi, T.B.: Alpha-fetoprotein synthesis by murine lymphoid cells in allogeneic reactions. J. Exp. Med.143, 1140–1153
Kuch, J.: Autoantibodies directed against heart antigens and endocrine reactivity in patients with recent myocardial infarction. Cardiovasc. Res.7, 649–654 (1973)
Lyon, E.: Virus disease and the cardiovascular system: A survey. New York, London: Grune & Stratton 1956
Maisch, B., Berg, P.A., Kochsiek, K.: Clinical significance of immunopathological findings in patients with postpericardiotomy syndrome. Part I: Relevance of antibody pattern in patients with complete and incomplete postpericardiotomy syndrome. Clin. Exp. Immunol.38, 189–197 (1979)
Maisch, B., Berg, P.A., Kochsiek, K.: Immunologische Differenzierung der Perikarditis nach Myokardinfarkt. Intensivmedizin16, 28–32 (1979)
McCabe, J.C., Ebert, P.A., Engle, M.A., Zabriskie, J.B.: Circulating heart — reactive antibodies in the post-pericardiotomy syndrome. J. Surg. Res.14, 158–164 (1973)
McFarland, H.F.: The effect of measles virus infection on T and B lymphocytes in the mouse. I. Suppression of helper cell activity. J. Immunol.113, 1978–1983 (1974)
Miller, F.: Serum-derived immunosuppressive substances. I. Partial purification and range of action. Transplantation21, 179–187 (1976)
Moorthy, A.V., Zimmermann, S.W., Burkholder, P.M.: Inhibition of lymphocyte blastogenesis by patients with minimal change-nephrotic syndrome. Lancet1976 I, II, 1160–1163
Morse, J.H.: Immunological studies of phytohaemagglutinin. I. Reaction between phytohaemagglutinin and normal sera. Immunology14, 713–724 (1968)
Mortensen, R.F., Gewurz, H.: Effects of C-reactive protein on the lymphoid system. II. Inhibition of mixed lymphocyte reactivity and generation of cytotoxic lymphocytes. J. Immunol.116, 1244–1250 (1976)
Murgita, R.A., Tomasi, T.B.: Suppression of the immune response by alpha fetoprotein. II. The effect of mouse alpha-fetoprotein on mixed lymphocyte reactivity and mitogeninduced lymphocyte transformation. J. Exp. Med.141, 440–452 (1975)
Nakao, M., Mizoguchi, Y., Monna, T., Yamamoto, S., Morisawa, S.: Studies on an inhibitory factor to phytohemagglutinin-induced lymphocyte transformation found in the serum of patients with various liver diseases. Acta Hepato-Gastroenterol.25, 335–343 (1978)
Nelson, D.S., Catti, R.A.: Humoral factors influencing lymphocyte transformation. Prog. Allergy21, 261–341 (1976)
Nelson, D.S., Schneider, C.N., Penrose, J.M.: Inhibition of lymphocyte transformation by products of macrophages and other cells. In: Mitogens in immunobiology. Oppenheim, J.J., Rosenstreich, D.L. (eds.), pp. 477–494. New York, London: Academic Press 1976
Newberry, M.W., Shorey, J.W., Sanford, J.P., Combes, B.: Depression of lymphocyte reactivity to phytohemagglutinin by serum from patients with liver disease. Cellular Immunology6, 87–97 (1973)
Panky, G.A.: Effect of viruses on the cardiovascular system. Am. J. Med. Sci.250, 103–114 (1965)
Penhale, W.J., Farmer, A., Maccuish, A.C., Irvine, W.J.: A rapid micro-method for the phytohaemagglutinin-induced human lymphocyte transformation test. Clin. Exp. Immunol.18, 155–167 (1974)
Rosenberg, B.J., Erlanger, B.F., Beiser, S.M.: Radioimmunochemical studies on nucleoside-specific antibodies using iodinated DNA. J. Immunol.108, 271–279 (1972)
Sachs, L.: Statistische Auswertungsmethoden. Berlin, Heidelberg, New York: Springer 1972
Tomasi, T.B.: Serum factors which suppress the immune response. In: Regulatory mechanisms in lymphocyte activation. pp. 219–250. Lucas, D.O. (eds.). London, New York: Academic Press 1977
Waksman, B.H., Namba, Y.: On soluble mediators of immunologic regulation. Cell. Immunol.21, 161–176 (1976)
Wands, J.R., Perrotto, J.L., Alpert, E., Isselbacher, K.J.: Cellmediated immunity in acute and chronic hepatitis. J. Clin. Invest.55, 921–929 (1975)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maisch, B., Berg, P.A. & Kochsiek, K. Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis. Klin Wochenschr 58, 219–225 (1980). https://doi.org/10.1007/BF01476967
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01476967
Schlüsselwörter
- Autoantikörper
- Antisarkolemmale Antikörper
- Antiendotheliale Antikörper
- Antimyokardiale Antikörper
- Immunsuppressive Serumfaktoren
- Seruminhibitionsfaktoren
- Akute und chronische Myokarditis
- Viruserkrankungen